141 results on '"Minna, John"'
Search Results
2. Abstract 871: KYNU expression is a prognostic factor in KEAP1/STK11 co-mutated lung adenocarcinoma
3. Abstract 203: SCLC-CellMiner: An extensive cell line genomic and pharmacology resource identifies a subgroup of small cell lung cancers sensitive to targeted therapies and immunotherapies
4. Abstract 22: A novel, inflamed small cell lung cancer transcriptional subtype, SCLC-I, defines a subset of patients with distinct immunotherapy vulnerability
5. Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses
6. Abstract 1030: Regulation and role of actin dynamics in promoting premalignant cell migration
7. Abstract 2710: Depletion of CXCR2-dependent myeloid-derived suppressor cells (MDSCs) overcomes anti-PD-1 resistance in a murine model of LKB1-deficient non-small cell lung cancer (NSCLC) with high mutational load
8. Abstract B09: Evaluating transcription factor networks as targets for the treatment of small cell lung cancer
9. Abstract IA12: Developing precision medicine-based new lung cancer therapeutics
10. Abstract 2664: Identification of two small molecules with small cell lung cancer growth inhibition response profiles different from etoposide/topotecan
11. Abstract 2015: Exosomes secreted by highly migratory premalignant lung epithelial cells promote epithelial mesenchymal transition and migration
12. Abstract 5740: PD-L1 overexpression induced by oncogenicKRASandBRAFmutations through MAPK pathway activation in non-small cell lung cancer
13. Abstract 3950: A novel combination therapy targeting BCL6 and phospho-STAT3 defeats intratumor heterogeneity in a subset of non-small cell lung cancers
14. Abstract 3328: Protochadherin 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesis
15. Abstract 907: Uptake of lung cancer exosomes induces migratory and invasive phenotypic changes in lung epithelial cells in an oncogene context dependent manner
16. Abstract 1111: The chromatin remodelers RUVBL1 and RUVBL2 are prognostic factors and therapeutic targets in non-small cell lung cancer due to their roles in DNA replication, repair, and radiosensitization
17. Abstract 532: Impact of APOBEC mutagenesis on the immune microenvironment of lung adenocarcinoma (LUAC)
18. Abstract 5170: Snail-dependent ESRP1 silencing drives malignant conversion of human pulmonary epithelial cells
19. Abstract 2324: FRA1 contributes to ERK-mediated increased PD-L1 expression in KRAS mutated premalignant human bronchial epithelial cells
20. Abstract 225: Assessing and enriching human tumor cell content in patient-derived cancer xenografts and co-cultures
21. Abstract 2961: Characterization of methylation profiles reveals distinct epigenomic patterns in SCLC and NSCLC
22. Abstract 2965: Identification of SMARCA4/BRG1 mutation types in NSCLC cell lines and tumors
23. Abstract 613: Copy number variations distinguish lung adenocarcinomas from squamous cell carcinomas
24. Abstract 968: Co-occurring genomic alterations define major subsets ofKRAS-mutant lung adenocarcinoma (LUAC) with distinct biology and therapeutic vulnerabilities
25. Abstract 4619: Protein palmitoylation in non-small cell lung cancer (NSCLC): DHHC5 palmitoyltransferase as a potential therapeutic target
26. Abstract A08: The role of miR-125a in the pathogenesis of lung cancer
27. Abstract 5589: Molecular signatures of in vitro drug response in lung cancer.
28. Abstract 4819: Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC)
29. Abstract 955: Specific forms of mutantKRASpredict patient benefit from targeted therapy in the BATTLE-1 clinical trial in advanced non-small cell lung cancer
30. Abstract A31: The role of microRNA 125a‐3P in the pathogenesis of lung cancer
31. Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer.
32. Differential Methylation of a Short CpG-Rich Sequence within Exon 1 of TCF21 Gene: A Promising Cancer Biomarker Assay.
33. CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.
34. Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations.
35. Genetic Mutation of p53 and Suppression of the miR-17~92 Cluster Are Synthetic Lethal in Non-Small Cell Lung Cancer due to Upregulation of Vitamin D Signaling.
36. A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets.
37. A Reevaluation of CD22 Expression in Human Lung Cancer.
38. KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer.
39. Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non--Small Cell Lung Cancer.
40. MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non-Small Cell Lung Cancer Patients.
41. SMAC Mimetic (JP1201) Sensitizes Non-Small Cell Lung Cancers to Multiple Chemotherapy Agents in an IAP-Dependent but TNF-α-Independent Manner.
42. From Mice and Men to Earth and Space: Joint NASA--NCI Workshop on Lung Cancer Risk Resulting from Space and Terrestrial Radiation.
43. Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non--Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy.
44. Dissecting signaling transduction network to infer master regulators of non-small cell lung cancer.
45. A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma.
46. Lung Cancer Cell of Origin: Controversy and Clinical Translational Implications.
47. Enhanced Vulnerability of LKB1-Deficient NSCLC to Disruption of ATP Pools and Redox Homeostasis by 8-Cl-Ado.
48. Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations.
49. Contemporary Lung Cancer Screening and the Promise of Blood-Based Biomarkers.
50. Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.